Topiroxostat microspherical preparation and preparation method thereof

A technology of topicastat and microspheres, applied in the field of topicastat microsphere preparations and their preparation, can solve the problems of limited clinical application, inconvenient taking, etc., and achieves increased route of administration, stable quality, and improved compliance. sexual effect

Active Publication Date: 2017-12-08
CP PHARMA QINGDAO CO LTD
1 Cites 1 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0005] However, the preparations developed above are all oral preparations, and their clinical application has limita...
View more

Method used

According to above-mentioned result, after adopting sodium stearate, Span20, Span80, Tween20 and Tween80 to substitute sodium lauryl sulfate in embodiment 2 as emulsifying agent in comparative example 6-10, prepared microsphere The encapsulation efficien...
View more

Abstract

The invention relates to the technical field of medicines and in particular relates to a topiroxostat microspherical preparation and a preparation method thereof. According to the technical scheme, the topiroxostat microspherical preparation is characterized by comprising the following components in parts by weight: 10-20 parts of topiroxostat, 30-100 parts of a macromolecular carrier, 0-5 parts of an emulsifier and 0-10 parts of a topiroxostat supporting agent. The topiroxostat microspheres are high in encapsulation efficiency, uniform in grain size, stable in quality and simple in preparation process, and the administrating path of topiroxostat is increased, and the patient compliance is enhanced; and moreover, the topiroxostat microspherical preparation also has a long-acting releasing effect of topiroxostat and achieves an unexpected technical effect.

Application Domain

Organic active ingredientsSkeletal disorder +3

Technology Topic

Long actingChemistry +3

Image

  • Topiroxostat microspherical preparation and preparation method thereof
  • Topiroxostat microspherical preparation and preparation method thereof
  • Topiroxostat microspherical preparation and preparation method thereof

Examples

  • Experimental program(3)
  • Effect test(1)

Example Embodiment

[0022] Example 1
[0023] Weigh 10g of topinostat, dissolve in 20mL of dichloromethane as the dispersed phase; weigh 40g of polylactic acid hydroxylactic acid and 3g of Span 80, dissolve in 100mL of ethanol aqueous solution as the continuous phase, slowly drop the dispersed phase into the organic phase Emulsify at 30°C and 2000r/min for 20min, pour the obtained emulsion into 400ml of acetone to solidify, wash the sediment with acetone until there is no oil drop; prepare 5% mannitol solution, take 100mL and add it to the sediment , stir evenly, and vacuum freeze-dry. The vacuum freeze-drying process is to pre-freeze at -40°C for 2 hours, slowly heat up to -5°C for 10 hours in vacuum, slowly heat up to 10°C for 8 hours in vacuum, and continue to heat up to 30°C for 1 hour in vacuum. The encapsulation rate of topicastat in the microspheres was 88.2±4.1%, and the particle size was 0.73±0.02 μm.

Example Embodiment

[0024] Example 2
[0025] Weigh 20g topinostat, dissolve it in 20mL chloroform as the dispersed phase; weigh 80g chitosan and 2g sodium lauryl sulfate, dissolve it in 200mL ethanol aqueous solution as the continuous phase, slowly drop the dispersed phase into the organic phase, ultrasonically emulsified for 30 minutes to form an oil-in-water emulsion; the organic solvent was removed by rotary evaporation at 40°C, 100 mL of 3% glucose solution was added, and vacuum freeze-drying was obtained. The vacuum freeze-drying process is pre-freezing at -30°C for 4 hours, slowly raising the temperature to 3°C for 12 hours in vacuum, slowly raising the temperature to 15°C for 6 hours, and continuing to heat up to 32°C for 2 hours in vacuum. The encapsulation rate of topicastat in the microspheres was 92.5±3.7%, and the particle size was 0.54±0.04 μm.

Example Embodiment

[0026] Example 3
[0027] Weigh 15g of topinostat and dissolve it in 20mL of dichloromethane; weigh 100g of polylactic acid and dissolve it in 200mL of ethanol aqueous solution, mix the two solutions and spray dry to prepare the topinostat microsphere preparation. The spray drying conditions are: atomization pressure 15MPa, feed liquid temperature 50°C, hot air temperature in the spray drying tower 110°C, feed pump speed 5r/min. The encapsulation rate of topicastat in the microspheres was 80.8±2.9%, and the particle size was 0.96±0.07 μm.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Preparation method of drug-loaded zinc oxide and silicon dioxide composite nanoparticles

InactiveCN109512800AHigh encapsulation efficiencydelayed release
Owner:SHENYANG PHARMA UNIVERSITY

Quinazoline molecular targeted medicinal composition

InactiveCN103372212AHigh encapsulation efficiencyPromote oral absorption
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI

Preparation method of Albendazole liposome preparation

InactiveCN108210460AHigh encapsulation efficiencyUniform particle size
Owner:ZHENGZHOU HOUYI PHARMA

Cilostazol liposome solid agent

ActiveCN112006992AHigh encapsulation efficiencygood solubility
Owner:药大制药有限公司

Classification and recommendation of technical efficacy words

  • High encapsulation efficiency
  • Uniform particle size

Fiber bracket containing growth factors and preparation method thereof

InactiveCN102397585AHigh encapsulation efficiencyReduced burst
Owner:WUXI ZHONGKE GUANGYUAN BIOMATERIALS

Preparation method of liposome for coating and carrying water soluble drugs

ActiveCN102188378Areduce complexityHigh encapsulation efficiency
Owner:ZHEJIANG HISUN PHARMA CO LTD

Sustained release drug nanofibers and preparation method thereof

ActiveCN108969470AHigh encapsulation efficiencymaintain biological activity
Owner:TSINGHUA UNIV

Preparation method for curcumin long circulating liposomes

InactiveCN103637988ASimple processHigh encapsulation efficiency
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Composite micelle carrying anti-tumor medicine and preparation method thereof

InactiveCN101732724AHigh encapsulation efficiencygood stability
Owner:ZHEJIANG UNIV

Preparation method of CaCu3Ti4O12 ceramic

Owner:NORTHWESTERN POLYTECHNICAL UNIV

Halogen-free flame-retardant temperature controlled microcapsules and preparation method thereof

InactiveCN104650929AUniform particle sizeGood electrical conductivity and thermal stability
Owner:SHANGHAI APPLIED TECHNOLOGIES COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products